Search & Analyze

Shilpa Medicare Ltd.

HealthcarePharmaceuticals & Drugs

www.vbshilpa.com BSE: 530549NSE: SHILPAMED

₹933.20BSE2.66%

16 Sep, 4:01 PM

₹933.20

₹17.83K Cr

59.98

6.64

9.82%

₹944.05

₹875.95

₹980.65

₹260.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.40	4,44,716.74	0.87	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.41	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.58	1,83,453.32	0.78	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.29	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.62	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	95.03	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.78	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
Shilpa Medicare Ltd. SHILPAMED	933.20	59.98	17,834.13	0.07	100.88	115.19%	465.78	44.89%	11.43

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	291.69	292.51	343.80	319.30	330.82	321.47	369.97	409.73	436.99	465.78
Expenses	221.63	218.99	257.79	238.66	251.62	229.84	261.69	295.43	317.28	329.52
	70.06	73.52	86.00	80.65	79.20	91.63	108.28	114.30	119.71	136.26
	24.02%	25.13%	25.02%	25.26%	23.94%	28.50%	29.27%	27.90%	27.39%	29.25%
	8.63	9.52	4.99	1.18	-22.95	6.38	1.75	-12.05	26.69	3.13
Interest	24.20	23.74	25.55	11.75	14.49	18.78	15.67	10.68	13.66	12.10
	26.63	27.11	28.28	28.81	28.79	28.92	29.82	30.36	30.62	35.20
	27.71	28.68	36.77	41.61	15.27	49.58	64.43	60.85	120.44	98.05
	11.59%	50.97%	51.20%	23.61%	4.98%	5.45%	31.60%	26.74%	10.50%	-2.89%
	24.50	14.06	17.94	31.78	14.51	46.88	44.07	44.58	107.79	100.88
	2.82	1.44	1.83	3.25	1.48	4.79	4.51	2.28	5.51	5.16

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	1,145.52	1,050.11	1,151.60	1,286.43	1,538.87
	1,145.52	1,050.11	1,151.60	1,286.43	1,538.87
EXPENDITURE :
Increase/Decrease in Stock	-7.02	14.98	-34.78	37.62	-36.22
Raw Material Consumed	390.24	401.06	429.01	359.75	479.08
Power & Fuel Cost	52.43	56.79	52.41	53.74	59.24
Employee Cost	264.49	286.39	281.39	292.71	334.88
Other Manufacturing Expenses	120.03	110.32	95.70	122.62	161.53
General and Administration Expenses	71.58	46.86	43.99	59.03	77.53
Selling and Distribution Expenses	29.36	18.56	21.42	26.52	46.60
Miscellaneous Expenses	27.22	26.89	26.96	28.19	35.34
	948.32	961.84	916.10	980.18	1,157.98
Operating Profit (Excl OI)	197.20	88.27	235.51	306.25	380.89
	20.90	31.41	17.16	36.45	63.65
	218.10	119.68	252.66	342.70	444.54
Interest	41.17	58.65	91.80	75.53	58.79
PBDT	176.94	61.03	160.86	267.17	385.75
	79.80	95.50	107.87	112.99	119.72
Profit Before Taxation & Exceptional Items	97.13	-34.47	52.99	154.18	266.03
Exceptional Income / Expenses	8.79		6.13	-30.58	12.16
	102.26	-38.28	54.34	122.33	295.31
Provision for Tax	41.68	-7.36	22.39	44.04	51.98
	60.58	-30.92	31.96	78.29	243.33
Extra items				0.00	0.00
Minority Interest	0.08	-1.56	-0.08
Consolidated Net Profit	60.66	-32.48	31.87	78.29	243.33
Profit Balance B/F	991.51	1,043.20	1,001.18	1,033.85	1,087.57
Appropriations	1,052.17	1,010.73	1,033.05	1,112.14	1,330.90
Equity Dividend %	110.00%			100.00%	60.00%
	6.99	-3.74	3.67	8.01	12.44
Adjusted EPS	3.49	-1.87	1.84	4.00	12.44

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	8.68	8.68	8.68	9.78	19.56
Total Reserves	1,813.51	1,774.60	1,800.01	2,352.92	2,571.64
Reserve excluding Revaluation Reserve	1,813.51	1,774.60	1,800.01	2,352.92	2,571.64
Revaluation reserve		0.00
	1,822.19	1,783.28	1,808.69	2,362.70	2,591.20
Minority Interest	-11.05	-8.92	-8.74	1.04
Secured Loans	353.49	242.92	560.16	231.96	183.81
Unsecured Loans	0.11	45.90
Deferred Tax Assets / Liabilities	54.74	14.05	-10.26	-12.97	-16.89
Other Long Term Liabilities	25.40	24.60	17.11	15.25	49.34
Long Term Provisions	19.08	17.65	22.43	25.54	33.20
Total Non-Current Liabilities	452.82	345.12	589.44	259.78	249.46
Trade Payables	146.04	142.80	174.15	104.91	142.47
Other Current Liabilities	240.13	276.56	138.05	213.19	252.92
Short Term Borrowings	202.90	344.17	360.73	306.81	411.56
Short Term Provisions	22.46	20.92	20.66	49.28	41.11
Total Current Liabilities	611.54	784.45	693.59	674.19	848.06
Total Liabilities	2,875.50	2,903.93	3,082.98	3,297.71	3,688.72
Gross Block	1,727.09	1,846.68	1,946.75	2,076.00	2,358.98
Less: Accumulated Depreciation	385.25	478.35	561.89	658.16	765.86
Net Block	1,341.84	1,368.33	1,384.86	1,417.84	1,593.12
Capital Work in Progress	190.04	358.04	403.00	462.52	431.20
Non Current Investments	34.23	42.66	39.91	34.54	57.94
Long Term Investment	34.23	42.66	39.91	34.54	57.94
Long Term Loans & Advances	93.90	56.53	53.32	37.71	42.67
Other Non Current Assets	12.15	11.52	9.87	1.34	1.17
Total Non-Current Assets	1,988.30	2,134.37	2,206.74	2,313.20	2,578.95
Inventories	355.24	319.82	344.93	347.93	366.79
Sundry Debtors	386.33	324.35	392.05	440.79	518.85
Cash and Bank	34.11	21.56	31.77	28.57	45.18
Other Current Assets	9.36	15.53	16.28	17.59	19.38
Short Term Loans and Advances	102.16	88.29	91.22	149.63	159.57
Total Current Assets	887.19	769.55	876.24	984.51	1,109.77
Net Current Assets (Including Current Investments)	275.66	-14.89	182.65	310.32	261.71
Total Assets	2,875.50	2,903.93	3,082.98	3,297.71	3,688.72
Contingent Liabilities	103.86	186.39	100.40	76.22	160.01
Total Debt	681.91	797.04	935.59	586.37	657.97
	209.93	205.44	208.37	241.58	132.47
Adjusted Book Value	104.96	102.72	104.19	120.79	132.47

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	102.26	-38.28	54.34	122.33	295.31
Adjustment	109.34	147.81	221.44	195.05	142.45
Changes In working Capital	-71.99	102.77	-97.92	-138.09	-35.17
Cash Flow after changes in Working Capital	139.62	212.30	177.86	179.29	402.59
Cash Flow from Operating Activities	105.13	179.92	136.67	132.27	342.18
Cash Flow from Investing Activities	-285.50	-232.61	-166.58	-199.13	-325.92
Cash Flow from Financing Activitie	82.86	45.80	46.78	62.65	13.62
Net Cash Inflow / Outflow	-97.51	-6.89	16.86	-4.21	29.88
Opening Cash & Cash Equivalents	122.85	25.62	19.07	31.76	28.57
Effect of Foreign Exchange Fluctuations		0.34	-4.18	1.02	-13.27
Closing Cash & Cash Equivalent	25.34	19.07	31.76	28.57	45.18

Ratios

Valuation

59.98

6.64

37.96

10.60

15.20

137.34

Profitability

9.82

11.43

6.97

24.75

15.81

Leverage & Liquidity

0.25

1.31

6.02

Returns

0.07

0.44

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	44.39	44.33	44.23	44.23	44.23	44.23	40.13	40.13	40.13
	16.69	17.76	18.17	18.52	18.64	18.57	19.30	19.66	19.43
	38.92	37.90	37.60	37.25	37.13	37.20	40.56	40.21	40.43
	55.61	55.67	55.77	55.77	55.77	55.77	59.87	59.87	59.87
No. of Shareholders	41,072	42,784	49,034	50,108	48,636	52,065	53,799	53,410	60,926

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-08-14	AGM
2026-07-29	Board Meeting	Quarterly Results
2026-05-22	Ex Dividend	Rs.0.6000 per share(60%)Final Dividend	2026-09-04	2026-09-04

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Shilpa Medicare Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Ritu Tiwary

Company Secretary & Compliance Officer

—

Omprakash Inani

Chairman

₹4.50 L

Mar '26

Vishnukant Bhutada

Managing Director

₹3.50 Cr

Mar '26

Sharath Reddy Kalakota

Whole Time Director

₹2.00 Cr

Mar '26

Kalakota Sharath Reddy

Whole Time Director

₹1.80 Cr

Mar '25

Hetal Madhukant Gandhi

Non Executive Independent Director

₹60.00 L

Mar '26

Anita Bandyopadhyay

Non Executive Independent Woman Director

₹18.00 L

Mar '26

Ashraf Loutfy Abdelhamid Allam

Non Executive Independent Director

₹22.20 L

Mar '26

SHILPAMED Latest News

News

10 of 10 articles

EQUITY11 Sept 2026 · 15:03

Shilpa Medicare rises on getting SEC’s final approval for OERIS

OERIS will be launched in India and enjoys patent protection in India until 2039

COMPANY11 Sept 2026 · 14:50

Shilpa Medicare gets SEC’s final approval for OERIS

OERIS will be launched in India and enjoys patent protection in India until 2039

EQUITY10 Sept 2026 · 17:40

Shilpa Medicare informs about initiation of NCLT order on FTF Pharma

EQUITY3 Aug 2026 · 11:47

Shilpa Medicare informs about appointment of CEO

EQUITY29 Jul 2026 · 16:23

Shilpa Medicare informs about board meeting

EQUITY30 Jun 2026 · 12:29

Shilpa Medicare informs about disclosure

COMPANY24 Jun 2026 · 09:58

Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility

This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing

EQUITY24 Jun 2026 · 09:39

Shilpa Medicare informs about press release

COMPANY3 Jun 2026 · 12:00

Shilpa Medicare’s arm enters into strategic equity partnership with Gate2Brain

G2B-002 delivers SN-38, a potent anticancer agent, across the blood-brain barrier via Gate2Brain's proprietary MiniAp4 peptide shuttle

EQUITY3 Jun 2026 · 09:54

Shilpa Medicare informs about press release

SHILPAMED

₹933.20

+2.66%